See related research by Elseviers *et al.*, <http://ccforum.com/content/14/6/R221>

In an observational study published in the previous issue of *Critical Care*, Elseviers and colleagues \[[@B1]\] report that the mortality of critically ill patients treated with renal replacement therapy (RRT) for acute kidney injury (AKI) is much higher than that of those treated by a conservative strategy (that is, without RRT). RRT remains an independent factor associated with a higher mortality after adjustments for acute disease severity (risk ratio \[RR\] 1.73, 95% confidence interval \[CI\] 1.4 to 2.2) based on the Stuivenberg Hospital Acute Renal Failure (SHARF) score as well as other corrections for usually well-established prognostic factors (age, sex, Sequential Organ Failure Assessment \[SOFA\] score, type of AKI, delayed admission, and clinical conditions). This observation might have two alternative explanations: first, RRT per se could worsen the prognosis of acutely ill patients experiencing AKI; second, AKI of patients treated by RRT was more severe and this greater severity is not fully reflected by the severity scores and adjustment factors used in the multivariable models of the study. In fact, the role of AKI, as an independent factor for mortality, is currently well documented, regardless of the severity of AKI \[[@B2],[@B3]\]. The subpopulation requiring RRT in the intensive care unit represents the more severe population, and the need for RRT appears to be an independent risk factor for death \[[@B4]\]. However, the need for renal supportive care is nonetheless a marker of severity. The specific role of RRT was first proposed by Guerin and colleagues \[[@B5]\] in their French epidemiological study. Indeed, they reported, in a multiple logistic regression analysis, that the absence of hemodialysis in their severe AKI population (serum creatinine \[sCr\] of greater than 300 μmol/L, urine output of less than 500 mL/24 hours, or the need for hemodialysis) was a significant predictor of survival (odds ratio 1.78, 95% CI 1.05 to 3.04; *P*0.032). This finding is of paramount importance given the current trend to initiate RRT early in the course of AKI. Moreover, recent epidemiological \[[@B6]\] or prospective controlled \[[@B7]\] studies show that the main criteria for RRT initiation are based on low urine output prior to a marked increase in sCr or serum urea level. RRT remains associated with a high mortality, and given the lack of survival improvement using continuous RRT \[[@B8]\] or augmented delivered dose \[[@B7],[@B9]\], early initiation of RRT might be promising. Actually, numerous retrospective studies report a better outcome with earlier initiation, but conflicting results are reported by other studies \[[@B10]\]. Finally, a recent meta-analysis \[[@B11]\] shows a barely significant decrease in mortality using early initiation of RRT in prospective studies (RR 0.64, 95% CI 0.40 to 1.05; *P*\< 0.08) and a significant decrease in mortality using early initiation of RRT in observational studies (RR 0.72, 95% CI 0.64 to 0.82; *P*\< 0.001). This new strategy seems attractive, but regarding the lack of strong data in favor of any beneficial effect, we should pay heed to the potential adverse effects. Unfortunately, the study by Elseviers and colleagues \[[@B1]\] presents many shortcomings, which hamper any definitive conclusion. First, the study is an observational trial and no prespecified criteria regarding RRT indications and the timing of initiation were provided in the dierent centers. This shortcoming may explain the heterogeneity in the rate of patients treated with RRT between the different centers and the associated mortality. Second, adjustment criteria did not take into account specific AKI characteristics, like oliguria, or specific prognostic scores based on metabolic disturbances (that is, RIFLE \[Risk, Injury, Failure, Loss, and End-stage kidney disease\] or AKIN \[Acute Kidney Injury Network\]). We can guess that intensivists were prompt to initiate RRT in patients with oliguria or severe metabolic abnormalities and thereby to select a more severe population. The higher mortality could be linked to the AKI severity itself rather than to a specific effect of RRT. The real problem in clinical practice is the early detection of AKI patients for whom RRT will be mandatory. In this population, we could probably start RRT early, whereas in the others, we could delay the initiation. As we wait for a large prospective study to test the benefit of early initiation of RRT, it seems reasonable, in the absence of a current clinical or biological marker of RRT requirement, to keep in mind that widespread use of early initiation may lead to an excess risk of complications and perhaps to a higher mortality than expected.
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